Cheng, Yu-Heng
Chen, Yu-Chih
Lin, Eric http://orcid.org/0000-0001-7571-1657
Brien, Riley
Jung, Seungwon
Chen, Yu-Ting
Lee, Woncheol
Hao, Zhijian
Sahoo, Saswat http://orcid.org/0000-0002-2151-9579
Min Kang, Hyun
Cong, Jason
Burness, Monika
Nagrath, Sunitha http://orcid.org/0000-0002-1497-7977
S. Wicha, Max
Yoon, Euisik
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35 CA 129765, R01 CA 203810, R21 CA 195016)
University of Michigan (2017 Translational Research Partnership Program)
Article History
Received: 17 September 2018
Accepted: 16 April 2019
First Online: 15 May 2019
Competing interests
: E.Y., Y.-H.C., Y.-C.C., and R.B. filed a patent application on the Hydro-Seq technology (Application No.: 62/449,867 and PCT/US2018/014353). S.N., E.L., and M.S.W. have a patent (US20150293010A1) on the Labyrinth enrichment technology. The remaining authors declare no competing interests.